Skip to content

Advertisement

BMC Obesity

Research article
Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Relationships between mitochondrial content and bioenergetics with obesity, body composition and fat distribution in healthy older adults

  • Manish S. Bharadwaj1,
  • Daniel J. Tyrrell1,
  • Iris Leng2,
  • Jamehl L. Demons1,
  • Mary F. Lyles1,
  • J. Jeffrey Carr3,
  • Barbara J. Nicklas1 and
  • Anthony J. A. Molina1Email author
BMC Obesity20152:40

https://doi.org/10.1186/s40608-015-0070-4

©  Bharadwaj et al. 2015

Received: 30 April 2015

Accepted: 21 September 2015

Published: 6 October 2015

Open Peer Review reports

Abstract

Background

Mitochondrial function declines with age; however, the relationship between adiposity and mitochondrial function among older adults is unclear. This study examined relationships between skeletal muscle mitochondrial content and electron transport chain complex 2 driven respiration with whole body and thigh composition, body fat distribution, and insulin sensitivity in older adults.

Methods

25 healthy, sedentary, weight-stable men (N = 13) and women (N = 12) >65 years of age, with a BMI range of 18-35 kg/m2, participated in this study. Vastus lateralis biopsies were analyzed for citrate synthase (CS) activity and succinate mediated respiration of isolated mitochondria. Whole body and thigh composition were measured by DXA and CT. HOMA-IR was calculated using fasting glucose and insulin as an estimate of insulin sensitivity.

Results

Similar to reports in middle-aged adults, skeletal muscle CS activity was negatively correlated with BMI (R = −0.43) in our cohort of older adults. Higher total and thigh adiposity were correlated with lower CS activity independent of BMI (R = −0.50 and −0.71 respectively). Maximal complex 2 driven mitochondrial respiration was negatively correlated with lower body adiposity in males (R = −0.66). In this cohort of non-diabetic older adults, both HOMA-IR and insulin were positively correlated with CS activity when controlling for BMI (R = 0.57 and 0.66 respectively).

Conclusions

Adiposity and body composition are correlated with skeletal muscle mitochondrial content and electron transport chain function in healthy, sedentary, community dwelling, older adults. Specific relationships of mitochondrial bioenergetics with gender and insulin sensitivity are also apparent.

Trial registration

ClinicalTrials.gov identifier NCT01049698

Keywords

MitochondriaMuscleAgingAdiposityObesity

Background

The increasing prevalence of obesity among older adults has led to growing concerns about numerous chronic health conditions in this population. Total adiposity, as well as fat deposition within specific anatomical regions (e.g., body fat distribution), is associated with impairments in physical function and higher incidence of disability in older age [1–6]. In addition, age-associated changes in body composition and fat distribution contribute to the increased prevalence of cardiometabolic disorders in this age group [7, 8]. Most notably, central adiposity is strongly associated with insulin resistance and its deleterious effects on glucose homeostasis even in older age [9]. On the other hand, higher lower body adiposity, commonly referred to as the “pear-shaped” body fat distribution, is more common in women and is associated with lower cardiometabolic risk [10, 11]. Thus, age and gender related differences in total and regional adiposity are likely underlying determinants of several deleterious changes in metabolic and physiologic function common with aging.

Aging-related bioenergetic decline is highlighted by mitochondrial impairments and reduced cellular energy supply. Skeletal muscle mitochondria are particularly sensitive to aging-related decline and have been reported to decrease ATP production, maximal respiratory capacity, mtDNA content, enzyme activity, and biogenesis with older age [12–17]. However, contributions of age-associated gains in body fat and shifts in body composition and fat distribution to declining mitochondrial function in older adults are not known. Studies in middle-aged adults have reported that differences in body composition and insulin resistance have profound effects on skeletal muscle mitochondrial metabolism [18–27]. Among the bioenergetic differences linked to obesity and insulin resistance in these previous studies, oxidative phosphorylation (OXPHOS) activity and mitochondrial content have been reported to be significantly reduced.

To date, few studies in elderly humans have investigated the links between properties of skeletal muscle mitochondria and obesity, body composition, body fat distribution, and insulin sensitivity. In the present study, we examined skeletal muscle bioenergetics in two ways; 1) citrate synthase (CS) activity, and 2) OXPHOS activity assessed by respirometric profiling of isolated organelles. CS activity is reported to be a reliable biomarker of mitochondrial content in skeletal muscle, as opposed to other measures such as mtDNA copy number [28]. Analysis of respiratory control in isolated mitochondria permits direct investigation of oxidative phosphorylation and has served as a standard readout of mitochondrial function for decades [29, 30]. Our purpose was to determine whether these mitochondrial readouts are associated with obesity, body composition, body fat distribution and insulin sensitivity in older men and women.

Methods

Participants

This study included 25 sedentary men (n = 13) and women (n = 12) recruited, using general media advertisements and mass mailings, to participate in a clinical trial of resistance training with or without dietary-induced weight loss. The assessments reported here were conducted at baseline, prior to intervention. All participants were older (65-79 years), sedentary (no regular exercise for >20 mins, 2 d/wk), with body mass index (BMI) between 18–35 kg/m2, in good health, weight stable for prior six weeks, had normal cognitive function, used no walking aids, and did not have uncontrolled diabetes or hypertension, abnormal liver or kidney function, or cancer requiring treatment in the past 2 years. Detailed inclusion and exclusion criteria have been previously reported [31, 32]. The study was approved by the Wake Forest School of Medicine Institutional Review Board and all participants provided written, informed consent to participate.

Skeletal muscle biopsy

Skeletal muscle tissue was obtained from the thigh muscle, specifically the vastus lateralis of the quadriceps, in the early morning after an overnight fast. Muscle was obtained using the percutaneous needle biopsy technique with a University College Hospital needle under local anesthesia with 1 %.

lidocaine as previously described [33]. Participants were asked to refrain from taking aspirin, prescription, or over-the-counter, nonsteroidal anti-inflammatory drugs, or other compounds that may affect bleeding, platelets, or bruising for the week prior to the biopsy, and were asked to refrain from any strenuous activity for at least 36 h prior to the biopsy.

Citrate synthase assay

Skeletal muscle (5 mg) was homogenized in 100 μl cold CelLytic MT (Sigma; St. Louis, MO) at pH 7.4 and protease inhibitor cocktail (Sigma, P8340). The homogenized sample was centrifuged at 12,000 g for 10 min and the supernatant containing the protein collected. 8 μg protein, as determined by BCA protein assay (Pierce; Rockford IL), was utilized per reaction in a final volume of 200 μl (Sigma, CS0720) at room temperature. In addition to protein, the reaction mixture contained 1X assay buffer, 300 μM acetyl CoA and 100 μM 5,5’-Dithiobis-(2-nitrobenzoic acid. The reaction was started by adding 500 μM Oxaloacetate. CS activity was measured by continuous spectrophotometric rate determination at 412 nm, according to manufacturer instructions. Each sample was run in triplicate.

Mitochondrial isolation

Mitochondria were isolated as previously described [33]. For each participant, ~50 mg of tissue was minced into small pieces and resuspended in Chappell-Perry Buffer I (CP I) containing Nagarse. After incubation with Nagarse for 5 min at room temperature, homogenization was performed using a Bio Gen series Model PRO200 homogenizer (Pro-Scientific, Inc., Oxford, CT) equipped with a 5 mm PRO quick connect generator probe. The homogenized tissue was washed with an equal volume of CP I and 2X volume of CP II buffer by centrifuging at 600 g, 4 °C, 10 min (Eppendorf centrifuge 5804R, Eppendorf AG, Hamburg, Germany). The resulting supernatant was filtered through cheese cloth and the filtrate centrifuged at 10,000 g, 4 °C, 10 min using a Beckman ultracentrifuge, Model J2-21 M Induction drive centrifuge (Beckman-Coulter, Inc., Brea, CA) to obtain a mitochondrial pellet. The pellet was further washed first with CP II and then with CP I buffer. Finally, the pellet was suspended in mitochondrial assay buffer (MAS: sucrose 35 mM, mannitol 110 mM, KH2PO4 2.5 mM, MgCl2 2.5 mM, HEPES 1.0 mM, EGTA 0.5 mM, Fatty-acid free BSA 0.10 %, pH 7.4) prior to respirometry. A typical yield of ~500 μg of purified mitochondria was obtained per 50 mg sample.

Mitochondrial respirometry

All respirometry assays were performed using an XF24–3 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA). The procedure was previously described by Rogers et. al. and focused on respiration driven solely by complex 2 [34]. During study protocol optimization, respiration driven by complex 1 using pyruvate/malate was compared with respiration driven by complex 2 using succinate/rotenone. Complex 2 driven respiration was consistently higher, similar to previous reports [34]. In order to ensure adequate sample size and standardization, all respirometric analyses of isolated mitochondria reported in this study were performed using succinate and rotenone. Compounds were prepared in 1X MAS at 10X the final concentration required for the assay. Final concentrations of compounds were as follows: 2 mM Adenosine 5’ –diphosphate (ADP), 2 μM oligomycin, 6 μM Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and 2 μM antimycin A. 5 μg of the mitochondrial suspension was added each well and the plate centrifuged at 2000 g, 4° C, for 20 min to ensure attachment. After centrifugation, 450 ml of 1X MAS containing succinate (10 mM) and rotenone (2 μM) was gently added to each well and the experiment initiated. The respirometric assay was performed at 37 °C. Primary outcomes were: maximal State 3 respiration, initiated with ADP; and State 4o, induced by the inhibition of ATP synthase by the addition of oligomycin. An average respiratory control ratio (RCR, State3/State 4o) of 4.5 +/− 1.3 in our studies indicate that mitochondria isolated using our protocol were viable.

Fasting insulin and insulin sensitivity index

Blood samples were collected in EDTA-treated vacutainer tubes via venipuncture in the early morning after an overnight fast, just prior to muscle biopsy. The samples were centrifuged at 4 °C for 20 min and plasma was separated and used to determine fasting plasma insulin (FPI) and fasting plasma glucose (FPG) levels. Insulin was determined using an automated immunoanalyzer (IMMULITE; Siemens Corporation, Washington DC). Insulin sensitivity was estimated using HOMA-IR calculated as (FPI × FPG)/22.5, as previously reported [35, 36].

Body composition and fat distribution

Total fat and lean mass, and percent body fat, were measured by dual-energy x-ray absorptiometry (DXA, Hologic Delphi QDR) by a certified technician. Whole body scans were acquired with the participant supine and aligned with the scanner table as prescribed by the manufacturer. A measure of lower body adiposity (leg-to-total fat mass) was calculated as fat mass in both legs divided by total body fat mass. Waist (minimal circumference) and hip (maximal gluteal protuberance) were measured in triplicate and averaged, and waist-to-hip ratio (WHR) was calculated. Thigh muscle and adipose tissue composition was measured on a 64 slice CT scanner (LightSpeed PlusTM, General Electric Medical Systems, Milwaukee) located in the WFSM Center for Biomolecular Imaging. Thigh scans were conducted at 120 KVp, 350 mA, 10 mm helical with a pitch of 11.25 mm/rotation and a gantry speed of 0.8 s. Measurements were performed on set of slices covering 50 mm of distance from the head to foot (z-axis) of the participant with the volume centered at the junction of the proximal and middle third of the femur as measured from the scout topogram. The volume of muscle (lean) and adipose tissue was segmented and measured using the GE Healthcare, Advantage Windows 4.2 Volume Viewer (Waukesha, WI).

Statistical analysis

Distributions of all variables were examined before any further analysis. Square root transformation of total lean mass, HOMA-IR, and insulin data was performed in order to normalize distribution. All other variables were normally distributed as assessed using Shapiro-Wilk tests. Potential differences between men and women with regard to demographics, obesity, adiposity, insulin sensitivity, and mitochondrial parameters were analyzed using unpaired two-tailed Student’s t-test (GraphPad Software, San Diego, CA). Associations between CS activity and respiration, and obesity and adiposity variables were assessed using Pearson correlation coefficients (R) for all participants and further adjusted for BMI alone, both BMI and gender; and BMI, gender, and age together. Correlation coefficients stratified by gender (and adjusted for BMI or both BMI and age) were also calculated. To examine associations between CS activity and mitochondrial respiration, and insulin sensitivity, similar correlation analyses as described above were performed (SPSS v22; Armonk, NY). Based on two-sided tests and a significance level of 0.05; with 25 participants total, we are able to detect a correlation of 0.55 or higher with a power of 82 %. For the analyses stratified by gender, with sample sizes of 13 men and 12 women, we are able to detect a correlation of 0.74 and 0.72 respectively, with a power of 81 %.

Results

Participant characteristics

Body composition, body fat distribution, insulin and glucose, and bioenergetic profiles are presented in Table 1 for all participants and split by gender. As expected, waist circumference, WHR, total lean mass and thigh muscle volume were higher in males, while total percent fat, and total and subcutaneous thigh fat volumes were higher in females. Women also had a higher ratio of leg-to-total fat mass, indicative of greater lower body adiposity (pear-shaped). No significant gender differences were observed for estimated insulin resistance (HOMA-IR).
Table 1

Demographics, Body Composition, Insulin, Glucose, and Mitochondrial Function of all Participants and Separated by Gender

 

All

Female

Male

 

Mean ± SD

Mean ± SD

Mean ± SD

P-value2

Age (years)

69.2 ± 3.7

69.2 ± 3.7

69.2 ± 3.8

0.97

BMI (kg/m2)

27.7 ± 5.1

26.3 ± 6.1

28.9 ± 3.8

0.22

Waist Circumference (cm)

90.7 ± 16.1

83.4 ± 18.0

97.4 ± 11.0

0.03

Waist/Hip ratio

0.9 ± 0.1

0.8 ± 0.2

0.9 ± 0.1

0.15

Total Fat Mass(kg)

28.6 ± 8.9

28.8 ± 10.9

28.3 ± 6.9

0.88

Total Lean Mass1 (kg)

7.14 ± 0.8

6.5 ± 0.5

7.8 ± 0.4

0.00

Percent Fat Mass

35.4 ± 6.9

39.5 ± 6.3

31.3 ± 4.8

0.00

Leg Fat Mass to Total Fat Mass ratio

0.3 ± 0.05

0.37 ± 0.05

0.30 ± 0.04

0.00

Total Thigh Fat (cm3)

647.0 ± 237.1

751.9 ± 256.5

550.2 ± 175.9

0.03

Thigh Subcutaneous Fat (cm3)

623.7 ± 226.4

727.5 ± 241.5

528.0 ± 168.4

0.02

Thigh Intermuscular Fat (cm3)

23.3 ± 15.9

24.4 ± 18.4

22.2 ± 13.9

0.74

Total Thigh Muscle (cm3)

648.4 ± 153.5

517.4 ± 86.0

769.4 ± 85.3

0.00

Thigh Intermuscular Fat/Total Thigh Fat Ratio

0.04 ± 0.02

0.03 ± 0.01

0.04 ± 0.02

0.27

HOMA-IR1

1.5 ± 0.5

1.3 ± 0.6

1.6 ± 0.5

0.12

Insulin (mIU/L)a

3.1 ± 1.0

2.7 ± 1.1

3.3 ± 0.9

0.14

Glucose (mmol/L)

5.1 ± 0.5

5.0 ± 0.4

5.3 ± 0.6

0.07

State 3 OCR (pmol/min/5 μg)

499.7 ± 200.3

459.5 ± 230.0

536.8 ± 169.2

0.35

State 4o OCR (pmol/min/5 μg)

123.1 ± 68.5

120.1 ± 68.5

125.8 ± 71.1

0.84

State 3u OCR (pmol/min/5 μg)

556.6 ± 315.2

487.5 ± 344.9

620.3 ± 283.8

0.30

Respiratory Control Ratio (RCR)

4.5 ± 1.3

4.0 ± 0.6

5.0 ± 1.6

0.06

Citrate Synthase Activity (μmol/min/mg)

175.1 ± 77.1

161.3 ± 82.4

190.2 ± 71.7

0.38

BMI body mass index, OCR oxygen consumption rate, RCR respiratory control ratio

aVariables were square-root transformed to achieve normal distribution, 2 Independent samples t-test between females (N = 12) and males (N = 11-13)

Associations of citrate synthase activity with body composition and body fat distribution

The correlation coefficients of CS activity with BMI, whole body and thigh composition, and body fat distribution are presented in Table 2. Additionally, Fig. 1 presents scatterplots with regression lines depicting the relationship of CS activity with BMI, total fat mass, total thigh fat volume, and intermuscular thigh fat volume. Additional file 1: Figure S1 presents scatterplots with regression lines depicting the relationship of CS activity with percent total fat and subcutaneous thigh fat. We report correlations with males and females combined and separated. For combined data, partial correlations with adjustments for BMI, BMI + gender, and BMI + gender + age are reported. For gender separated data, adjustment for BMI and BMI + age is also presented. In men and women combined, skeletal muscle CS activity correlated negatively with obesity measured by BMI (R = −0.43, P = 0.039), and with measures of adiposity (total fat mass (R = −0.62, P = 0.002), percent fat (R = −0.62, P = 0.002); and total (R = −0.76, P = 0.0001), subcutaneous (R = −0.76, P = 0.0001), and intermuscular thigh fat volumes (R = −0.48, P = 0.021)). Except for intermuscular thigh fat volume, these relationships were independent of BMI, gender, and age. After adjustment for BMI, there were positive correlations between CS activity and lean mass (R = 0.43, P = 0.039) and thigh muscle volume (R = 0.53, P = 0.014) in both men and women. The contribution of BMI in CS activity correlations with total fat mass and percent fat, were different between men and women. Namely, controlling for BMI in women diminished the correlation between CS activity and total body fat (R = −0.59, P = 0.02 and R = −0.18, P = 0.60, respectively). We also observed a significant negative correlation between CS activity and leg-to-total fat ratio in both men and women after adjustment for BMI (R = −0.64, P = 0.002), indicating that higher lower body adiposity is negatively correlated with CS activity.
Table 2

Citrate Synthase Activity Correlation Coefficients with Obesity and Total and Thigh Body Composition and Body Fat Distribution for All Participants and Split by Gender

 

Both Genders

Female

Males

Pearson

Partial (BMI)

Partial (BMI + gender)

Partial (BMI + gender + age)

Pearson

Partial (BMI)

Partial (BMI + age)

Pearson

Partial (BMI)

Partial (BMI + age)

BMI (kg/m2)

−0.43*

n/a

n/a

n/a

−0.57

n/a

n/a

−0.41

n/a

n/a

Waist Circumference (cm)

−0.30

0.20

0.07

0.21

−0.44

0.19

0.06

−0.40

−0.40

0.06

Waist/Hip ratio

−0.07

0.15

0.10

0.17

−0.11

0.10

−0.03

−0.24

0.29

0.45

Total Fat Mass (kg)

−0.62**

−0.50*

−0.41

−0.41

−0.59*

−0.18

−0.16

−0.68*

−0.88**

−0.87*

Total Lean Massa (kg)

−0.01

0.43*

0.37

0.35

−0.32

0.41

0.46

−0.08

0.34

0.17

Percent Fat Mass

−0.62**

−0.48*

−0.47*

−0.47*

−0.57

−0.15

−0.16

−0.83**

−0.88**

−0.84**

Leg Fat Mass to Total Fat Mass ratio

−0.161

−0.64**

−0.59**

−0.60**

0.01

−0.75**

−0.76*

−0.31

−0.46

−0.53

Thigh Fat Volume (cm3)

−0.76***

−0.71***

−0.80***

−0.71***

−0.80**

−0.77**

−0.81**

−0.68*

−0.84**

−0.56

Thigh Subcutaneous Fat (cm3)

−0.76***

−0.72***

−0.81***

−0.72***

−0.82***

−0.80**

−0.83**

−0.67*

−0.82**

−0.55

Thigh Intermuscular Fat (cm3)

−0.48*

−0.24

−0.15

−0.11

−0.46

−0.07

−0.30

−0.51

−0.29

0.10

Total Thigh Muscle (cm3)

0.20

0.53*

0.52*

0.53*

−0.18

0.56

0.56

0.37

0.53

0.30

Thigh Intermuscular Fat/Total Thigh Fat Ratio

−0.18

0.10

0.07

0.11

−0.13

0.28

0.17

−0.33

−0.06

0.22

BMI body mass index

aVariables were square-root-transformed to achieve normal distribution

* = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001

Females: N = 12; Males: N = 10-11

Fig. 1

Regression analysis comparing Vastus lateralis mitochondrial content, measured as citrate synthase enzyme activity with representative body composition variables (BMI, DXA total fat mass, CT total thigh fat volume, and intermuscular thigh fat volume). Relationships between citrate synthase enzyme activity and adiposity variables.

Association of mitochondrial respiration with body composition and body fat distribution

The correlation coefficients of complex 2 driven mitochondrial respiratory state 3 (maximal) with BMI, total body and thigh composition, and body fat distribution are presented in Table 3. Additionally, Fig. 2 presents scatterplots with regression lines depicting the specific correlations with BMI, total fat mass, thigh fat volume, and intermuscular thigh fat volume. In males, maximal state 3 OCR significantly correlates with lower body adiposity (R = −0.66, P = 0.019). Analysis of state 4o respiration (Table 4) indicates that there are no significant correlations with obesity and body composition. The correlation coefficients of RCR (state 3/state 4o) with BMI, total body and thigh composition, and body fat distribution are presented in Additional file 2: Table S1. RCR is positively correlated with blood glucose (R = 0.48, P = 0.016). Gender separated data indicate a significant negative correlation with total thigh fat (R = −0.69, P = 0.019) and subcutaneous thigh fat (R = −0.71, P = 0.015) after adjusting for BMI in women. Likewise, a strong positive correlation is seen with HOMA-IR and insulin after adjusting for BMI (R = 0.63, P = 0.038, and R = 0.64, P = 0.036 respectively) in women.
Table 3

State 3 Respiration Correlation Coefficients with Obesity and Total and Thigh Body Composition and Body Fat Distribution for All Participants and Split by Gender

 

Both Genders

Female

Male

Pearson

Partial (BMI)

Partial (BMI + gender)

Partial (BMI + gender + age)

Pearson

Partial (BMI)

Partial (BMI + age)

Pearson

Partial (BMI)

Partial (BMI + age)

BMI (kg/m2)

−0.22

n/a

n/a

n/a

−0.32

n/a

n/a

−0.26

n/a

n/a

Waist Circumference (cm)

−0.01

0.33

0.27

0.49*

−0.17

0.27

0.39

−0.06

0.29

0.76**

Waist/Hip ratio

0.19

0.29

0.28

0.45*

0.16

0.28

0.48

0.16

0.41

0.48

Total Fat Mass (kg)

−0.32

−0.14

0.00

0.10

−0.28

0.08

0.09

−0.41

−0.26

0.17

Total Lean Massa (kg)

0.061

0.25

0.14

0.17

−0.26

0.03

0.06

0.04

0.40

0.36

Percent Fat Mass

−0.35

−0.20

−0.04

0.04

−0.23

0.16

0.16

−0.50

−0.47

−0.13

Leg Fat Mass to Total Fat Mass ratio

0.01

−0.05

0.00

−0.10

0.37

0.26

0.26

−0.66*

−0.68*

−0.71*

Total Thigh Fat (cm3)

−0.29

−0.12

0.07

0.14

−0.13

0.33

0.32

−0.38

−0.59

−0.11

Thigh Subcutaneous Fat (cm3)

−0.30

−0.14

0.04

0.11

−0.13

0.32

0.32

−0.39

−0.62

−0.15

Thigh Intermuscular Fat (cm3)

−0.08

0.17

0.25

0.40

−0.08

0.24

0.29

−0.44

0.33

0.60

Total Thigh Muscle (cm3)

0.12

0.14

−0.07

−0.03

−0.49

−0.42

−0.36

0.28

0.37

0.14

Thigh Intermuscular Fat/Total Thigh Fat Ratio

0.15

0.27

0.26

0.37

−0.01

0.18

0.31

0.25

0.56

0.57

BMI body mass index

aVariables were square-root-transformed to achieve normal distribution

* = p ≤ 0.05, ** = p ≤ 0.01,

Females: N = 12; Males: N = 12-13

Fig. 2

Regression analysis comparing Vastus lateralis mitochondrial state 3 respiration, measured as OCR in response to saturating ADP, with representative body composition variables (BMI, DXA total fat mass, CT total thigh fat volume, and intermuscular thigh fat volume) Relationships between state 3 respiration, BMI, and adiposity variables

Table 4

State 4o Respiration Correlation Coefficients with Obesity and Total and Thigh Body Composition and Body Fat Distribution for All Participants and Split by Gender

 

Both Genders

Female

Male

Pearson

Partial (BMI)

Partial (BMI + gender)

Partial (BMI + gender + age)

Pearson

Partial (BMI)

Partial (BMI + age)

Pearson

Partial (BMI)

Partial (BMI + age)

BMI (kg/m2)

−0.24

n/a

n/a

n/a

−0.20

n/a

n/a

−0.35

n/a

n/a

Waist Circumference (cm)

−0.09

0.19

0.24

0.43*

−0.06

0.28

0.38

−0.20

0.24

0.58

Waist/Hip ratio

0.19

0.29

0.28

0.36

0.27

0.38

0.47

−0.17

−0.08

0.11

Total Fat Mass (kg)

−0.28

0.11

0.12

0.13

−0.16

0.13

0.12

−0.52

0.08

0.19

Total Lean Massa (kg)

−0.13

0.05

0.20

0.14

−0.16

0.02

0.07

−0.12

0.40

0.21

Percent Fat Mass

−0.18

0.04

0.00

0.07

−0.10

0.20

0.16

−0.55

−0.23

0.03

Leg Fat Mass to Total Fat Mass ratio

0.15

−0.00

−0.02

−0.06

0.35

0.29

0.28

−0.26

−0.38

−0.39

Thigh Fat Volume (cm3)

−0.12

0.15

0.19

0.29

0.03

0.46

0.42

−0.31

−0.27

0.23

Thigh Subcutaneous Fat (cm3)

−0.12

0.14

0.17

0.26

0.03

0.45

0.12

−0.31

−0.30

0.19

Thigh Intermuscular Fat (cm3)

−0.09

0.24

0.23

0.31

0.02

0.25

0.33

−0.22

0.29

0.37

Total Thigh Muscle (cm3)

−0.01

−0.04

−0.01

0.00

−0.40

−0.40

−0.33

0.22

0.26

0.03

Thigh Intermuscular Fat/Total Thigh Fat Ratio

−0.03

0.19

0.20

0.18

0.03

0.19

0.29

−0.07

0.43

0.27

BMI body mass index

aVariables were square-root-transformed to achieve normal distribution

* = p ≤ 0.05

Females: N = 13, Males: N = 12-13

Relationships with estimated insulin sensitivity

The correlation coefficients of CS activity, state 3, and state 4o OCR with estimated insulin resistance (HOMA-IR), fasting insulin, and glucose are presented in Table 5. CS activity correlated positively with fasting insulin (R = 0.66, P = 0.0001) and HOMA-IR (R = 0.57, P = 0.002) after controlling for BMI (Additional file 3: Figure S2). Gender separated data indicate similar results between men and women.
Table 5

Correlation Coefficients for Mitochondrial Measures and Glucose/Insulin for All Participants and Split by Gender

 

Both Genders

Female

Male

Pearson

Partial (BMI)

Partial (BMI + gender)

Partial (BMI + gender + age)

Pearson

Partial (BMI)

Partial (BMI + age)

Pearson

Partial (BMI)

Partial (BMI + age)

Citrate Synthase Associations

          

HOMA-IRa

0.21

0.57**

0.55*

0.58**

0.08

0.62*

0.61

0.26

0.46

0.53

Insulin (mIU/L)a

0.20

0.66***

0.63**

0.60**

0.09

0.71*

0.63

0.25

0.49

0.51

Glucose (mmol/L)

0.19

0.31

0.25

0.34

0.09

0.58

0.61

0.18

0.05

0.44

State 3 OCR Associations

          

HOMA-IRa

−0.19

−0.27

−0.32

−0.12

−0.53

−0.45

−0.39

−0.08

−0.05

0.20

Insulin (mIU/L)a

−0.19

−0.24

−0.31

−0.13

−0.51

−0.43

−0.39

0.08

0.00

0.19

Glucose (mmol/L)

−0.07

−0.22

−0.30

−0.02

−0.35

−0.22

−0.17

−0.05

−0.58

0.14

State 4o OCR Associations

          

HOMA-IRa

−0.27

−0.39

−0.39

−0.16

−0.54

−0.53

−0.45

−0.06

−0.21

0.10

Insulin (mIU/L)a

−0.27

−0.36

−0.36

−0.16

−0.52

−0.52

−0.46

−0.05

−0.15

0.10

Glucose (mmol/L)

−0.21

−0.38

−0.38

−0.07

−0.33

−0.26

−0.18

−0.20

−0.72*

0.01

BMI body mass index, HOMA-IR homeostatic model assessment of insulin resistance, OCR oxygen consumption rate

aVariables were square-root-transformed to achieve normal distribution

* = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001

Females: N = 12, Males: N = 11-13

Discussion

Age related bioenergetic decline has been associated with numerous age related diseases and is thought to be mediated by numerous factors such as mitochondrial DNA mutations and oxidative stress [37, 38]. Among the physiological changes that occur with aging, there is growing concern that increased adiposity and changes in body fat distribution lead not only to increased cardiometabolic risk, but also increased risk for disability. Recent studies have highlighted the significance of skeletal muscle mitochondrial function in the physical ability of older adults [31, 39–41]. However, little is known about the relationship of obesity, adiposity, and mitochondrial bioenergetics in this age group. In this manuscript, we present evidence that bioenergetic deficits among older adults are related to differences in adiposity and body fat distribution. Our data indicate that older men and women with a higher BMI as well as total and thigh adiposity have lower skeletal muscle (vastus lateralis) CS activity, a biomarker of mitochondrial content [28]. In particular, thigh adiposity was strongly associated with low mitochondrial mass, independent of BMI. The apposition of thigh adipose tissue to vastus lateralis may contribute to the strength of this correlation. A possible interpretation of our findings is that changes in body composition related to aging can contribute to age-related bioenergetic decline. Alternatively, alterations in mitochondrial function may play a role in altering body fat distribution with aging. Longitudinal studies are required in order to understand the cause and effect relationship of bioenergetic decline and age-related changes in adiposity and body fat distribution.

In addition to age, gender is known to underlie differences in regional fat deposition and body composition. While women generally have more body fat than men, the pear-shaped body fat distribution is thought to contribute to lower cardiometabolic risk [10, 11, 42]. It has been suggested that gluteal-femoral adipose tissues may represent a safe lipid reservoir or may directly regulate systemic metabolism via release of metabolic products or adipokines [11]. In this study, we analyzed the relationship of adiposity and skeletal muscle mitochondria across genders, as well as in men and women alone. We observe that thigh fat volume, particularly in the subcutaneous depot, is strongly associated with low skeletal muscle mitochondrial content regardless of gender. When controlling for BMI, a higher ratio of leg fat to total fat was associated with lower skeletal muscle mitochondrial content.

Skeletal muscle bioenergetic decline has been previously associated with diabetes and insulin resistance [21, 22, 43, 44]. Both blood insulin and HOMA-IR positively correlated with mitochondrial mass when controlling for BMI. A potential interpretation of this result is that in healthy older adults, CS activity may increase in relation to mild insulin resistance. Our cohort of healthy, non-diabetic, older adults had an average HOMA-IR of 1.5 ± 0.5. It is conceivable that higher levels of insulin resistance are required before deleterious effects on mitochondrial content are observed. Future studies across a wider range of insulin sensitivities are required in order to determine at what point mitochondrial content is decreased.

A recent study reported that state 3 respiration of skeletal muscle is significantly reduced in obese individuals compared to lean controls even when normalizing for mitochondrial content [26]. Furthermore, they report that weight loss with bariatric surgery was able to improve mitochondrial function one year after surgery. In this study, we examined intrinsic mitochondrial function by profiling mitochondrial respiration driven by electron transport chain (ETC.) complex 2 in isolated organelles. In separate studies of obese and older adults, increased activity of complexes 2–4 (assessed by succinate oxidase activity) has been reported with exercise intervention [14, 45]. In the present study, the correlation between complex 2 driven state 3 OCR, a measure of maximal mitochondrial respiration, with adiposity, expressed as percent fat measured by DXA, did not reach statistical significance. Examination of gender separated data suggests that these correlations, while not statistically significant, are stronger in men compared to women. Interestingly, lower body adiposity in men was significantly associated with lower state 3 respiration. Taken together, these data suggest that lower body adiposity may be more detrimental to vastus lateralis mitochondrial content as well as intrinsic mitochondrial function in men compared to women. On the other hand, our data also indicate that the association of insulin resistance and intrinsic mitochondrial function is stronger in women, although not reaching statistical significance in this study. These data suggest that ETC. dysfunction, evident with mild insulin resistance, may be related to multiple mitochondrial changes others have reported in diabetic patients [20–22, 44]. It should be noted that various mitochondrial isolation techniques can result in altered bioenergetic function, such as significantly increased RCR compared with permeabilized myofibers accompanied by significantly reduced time to mitochondrial permeability transition pore opening and greater reactive oxygen species production [46]. The use of mitochondrial isolation methodologies is a potential limitation to our study and must be considered in the interpretation of our results. Future studies should be undertaken in order to more comprehensively examine respiration driven by complex 1 and β-oxidation, in addition to complex 2. Such studies will likely require significantly larger amounts of biopsied tissue if performed in isolated mitochondria. A potentially powerful approach would be to perform respirometric analysis of permeabilized muscle fibers. Smaller sample requirements can allow for more comprehensive analysis of mitochondrial function. Moreover potential damage associated with mitochondrial isolation procedures can be avoided [46]. In addition, mitochondrial function can be affected by a number of other factors; including, ROS production, calcium retention capacity, and apoptotic susceptibility. These can be examined using methodologies similar to those that have been described for respirometry with combined fluorometry [47–50].

Conclusion

Changes in adiposity and body fat distribution associated with aging are thought to play an important role in the cardiometabolic health and physical ability of older adults. While it is apparent that adiposity and body fat distribution negatively impact skeletal muscle mitochondrial bioenergetics in middle aged adults, relatively little is known about the relationship of adiposity on mitochondrial function in older adults, a population that has been shown to exhibit systemic bioenergetic decline. This study is the first to report that differences in total adiposity as well as body fat distribution among healthy, community dwelling, older adults are related to skeletal muscle mitochondrial bioenergetics as reported by both citrate synthase activity and intrinsic electron transport chain function driven by complex 2. Specific relationships of mitochondrial bioenergetics with gender and insulin sensitivity were apparent and reveal important areas for future research.

Abbreviations

BMI: 

Body mass index

CP: 

Chappel-Perry

CS: 

Citrate synthase

CT: 

Computed tomography

DXA: 

Dual energy X-ray absorptiometry

ETC.: 

Electron transport chain

FCCP: 

Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone

FPG: 

Fasting plasma glucose

FPI: 

Fasting plasma insulin

HOMA-IR: 

Homeostatic model assessment-estimated insulin resistance

MAS: 

Mitochondria assay solution

mtDNA: 

Mitochondrial DNA

OCR: 

Oxygen consumption rate

RCR: 

Respiratory control ratio

WHR: 

Waist-to-hip ratio

Declarations

Acknowledgements

We thank the men and women who volunteered for this study as well as the research staff who conducted the recruitment and assessments. We also thank Dr. Susan Fried (Boston University) for her insights during the preparation of this manuscript. This work was supported by National Institutes of Health grants 5R01-AG020583 and 3R01-AG020583-09S1, and the Wake Forest Claude D. Pepper Older Americans Independence Center (P30-AG21332).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Sticht Center on Aging & Department of Internal Medicine, Section on Gerontology and Geriatrics, Wake Forest School of Medicine, Winston-Salem, USA
(2)
Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, USA
(3)
Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, USA

References

  1. Beavers KM, Beavers DP, Houston DK, Harris TB, Hue TF, Koster A, et al. Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study. Am J Clin Nutr. 2013;97:552–60.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Han TS, Tajar A, O'Neill TW, Jiang M, Bartfai G, Boonen S, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003–11.View ArticlePubMedGoogle Scholar
  3. James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336–52.View ArticlePubMedGoogle Scholar
  4. Jensen GL. Obesity and functional decline: epidemiology and geriatric consequences. Clin Geriatr Med. 2005;21:677–87. v.View ArticlePubMedGoogle Scholar
  5. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–200.View ArticlePubMedGoogle Scholar
  6. Rejeski WJ, Marsh AP, Chmelo E, Rejeski JJ. Obesity, intentional weight loss and physical disability in older adults. Obes Rev. 2010;11:671–85.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Coin A, Sergi G, Inelmen EM, Enzi G. Pathophysiology of body composition changes in elderly people. In Cachexia and wasting: a modern approach. Springer, Milan; 2006:369–375.Google Scholar
  8. St-Onge MP. Relationship between body composition changes and changes in physical function and metabolic risk factors in aging. Curr Opin Clin Nutr Metab Care. 2005;8:523–8.PubMedGoogle Scholar
  9. Nilsson G, Hedberg P, Jonason T, Lonnberg I, Tenerz A, Forberg R, et al. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Intern Med. 2008;19:520–6.View ArticlePubMedGoogle Scholar
  10. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010;34:949–59.View ArticleGoogle Scholar
  11. Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012;3:13.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem. 2000;275:3343–7.View ArticlePubMedGoogle Scholar
  13. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM, et al. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol. 1992;47:B71–6.View ArticlePubMedGoogle Scholar
  14. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61:534–40.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140–2.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Rooyackers OE, Adey DB, Ades PA, Nair KS. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci U S A. 1996;93:15364–9.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52:1888–96.View ArticlePubMedGoogle Scholar
  18. Chanseaume E, Barquissau V, Salles J, Aucouturier J, Patrac V, Giraudet C, et al. Muscle mitochondrial oxidative phosphorylation activity, but not content, is altered with abdominal obesity in sedentary men: synergism with changes in insulin sensitivity. J Clin Endocrinol Metab. 2010;95:2948–56.View ArticlePubMedGoogle Scholar
  19. Hernandez-Alvarez MI, Thabit H, Burns N, Shah S, Brema I, Hatunic M, et al. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care. 2010;33:645–51.View ArticlePubMedGoogle Scholar
  20. Hwang H, Bowen BP, Lefort N, Flynn CR, De Filippis EA, Roberts C, et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes. 2010;59:33–42.View ArticlePubMedGoogle Scholar
  21. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944–50.View ArticlePubMedGoogle Scholar
  22. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100:8466–71.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Rabol R, Hojberg PM, Almdal T, Boushel R, Haugaard SB, Madsbad S, et al. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. J Clin Endocrinol Metab. 2009;94:1372–8.View ArticlePubMedGoogle Scholar
  24. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab. 2010;298:E49–58.View ArticlePubMedGoogle Scholar
  25. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia. 2007;50:113–20.View ArticlePubMedGoogle Scholar
  26. Vijgen GH, Bouvy ND, Hoeks J, Wijers S, Schrauwen P, van Marken Lichtenbelt WD. Impaired skeletal muscle mitochondrial function in morbidly obese patients is normalized one year after bariatric surgery. Surg Obes Relat Dis. 2013;9:936–41.View ArticlePubMedGoogle Scholar
  27. Wijngaarden MA, van der Zon GC, van Dijk KW, Pijl H, Guigas B. Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. Am J Physiol Endocrinol Metab. 2013;304:e1012–21.Google Scholar
  28. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, et al. Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol. 2012;590:3349–60.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435:297–312.View ArticlePubMedPubMed CentralGoogle Scholar
  30. CHANCE B, Williams GR. A simple and rapid assay of oxidative phosphorylation. Nature. 1955;175:1120–1.View ArticlePubMedGoogle Scholar
  31. Tyrrell DJ, Bharadwaj MS, Van Horn CG, Kritchevsky SB, Nicklas BJ, Molina AJ. Respirometric Profiling of Muscle Mitochondria and Blood Cells Are Associated With Differences in Gait Speed Among Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci 2014 doi:10.1093/gerona/glu096.
  32. Nicklas BJ, Chmelo E, Delbono O, Carr JJ, Lyles MF, Marsh AP. Effects of resistance training with and without caloric restriction on physical function and mobility in overweight and obese older adults: a randomized controlled trial. Am J Clin Nutr. 2015;101:991–9.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Bharadwaj MS, Tyrrell DJ, Lyles MF, Demons JL, Rogers GW, Molina AJA. Preparation and Respirometric Assessment of Mitochondria Isolated from Skeletal Muscle Tissue Obtained by Percutaneous Needle Biopsy. J Vis Exp. 2015 Feb 7;(96). doi:10.3791/52350.
  34. Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One. 2011;6:e21746.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.View ArticlePubMedGoogle Scholar
  36. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.View ArticlePubMedGoogle Scholar
  37. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309:481–4.View ArticlePubMedGoogle Scholar
  38. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1989;1:642–5.View ArticlePubMedGoogle Scholar
  39. Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW et al. Skeletal Muscle Mitochondrial Energetics Are Associated With Maximal Aerobic Capacity and Walking Speed in Older Adults. J Gerontol A Biol Sci Med Sci. 2013;68(4):447-455.Google Scholar
  40. Joseph AM, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM, et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell. 2012;11:801–9.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Joseph AM, Adhihetty PJ, Wawrzyniak NR, Wohlgemuth SE, Picca A, Kujoth GC, et al. Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging. PLoS One. 2013;8:e69327.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339–48.View ArticlePubMedGoogle Scholar
  43. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 2007;56:1376–81.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–73.View ArticlePubMedGoogle Scholar
  45. Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab. 2005;288:e818–25.Google Scholar
  46. Picard M, Ritchie D, Wright KJ, Romestaing C, Thomas MM, Rowan SL, et al. Mitochondrial functional impairment with aging is exaggerated in isolated mitochondria compared to permeabilized myofibers. Aging Cell. 2010;9:1032–46.View ArticlePubMedGoogle Scholar
  47. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009;119:573–81.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Anderson EJ, Neufer PD. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol. 2006;290:C844–51.View ArticlePubMedGoogle Scholar
  49. Kane DA, Lin CT, Anderson EJ, Kwak HB, Cox JH, Brophy PM, et al. Progesterone increases skeletal muscle mitochondrial H2O2 emission in nonmenopausal women. Am J Physiol Endocrinol Metab. 2011;300:E528–35.View ArticlePubMedGoogle Scholar
  50. Gouspillou G, Rouland R, Calmettes G, Deschodt-Arsac V, Franconi JM, Bourdel-Marchasson I, et al. Accurate determination of the oxidative phosphorylation affinity for ADP in isolated mitochondria. PLoS One. 2011;6:e20709.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Bharadwaj et al. 2015

Advertisement

BMC Obesity

ISSN: 2052-9538

Contact us